ANVS
Annovis BioFNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
ANVS vs peer average
18/100
ANVS vs. peer average (F vs. C)
Grade spread
A 2 · B 3 · C 2 · D 1 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
RDY is the first available peer comparator.
Small-cap biotech with early-stage CNS programs; serves as a comparable for development-stage binary risk.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ANVS
Annovis Bio
RDY
Dr Reddy's Laboratories
Grade
F
C
Momentum
13
35
Value
41
65
Sentiment
0
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs RDY
ANVS / RDY
Grade Position
Below peers
ANVS vs. peer average (F vs. C)
18/100
Momentum
13
RDYValue
41
RDYSentiment
0
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ANVS
RDY is the first peer returned for this comparison set.

